Sumitomo Mitsui Trust Holdings Inc. Trims Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sumitomo Mitsui Trust Holdings Inc. trimmed its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 87.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 67,499 shares of the medical instruments supplier’s stock after selling 457,064 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $2,402,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. VisionPoint Advisory Group LLC raised its stake in shares of DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 395 shares during the period. Anchor Investment Management LLC acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $47,000. Exchange Traded Concepts LLC grew its holdings in shares of DENTSPLY SIRONA by 41.2% in the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 439 shares in the last quarter. Creative Financial Designs Inc. ADV acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $71,000. Finally, CWM LLC grew its holdings in shares of DENTSPLY SIRONA by 85.5% in the third quarter. CWM LLC now owns 4,379 shares of the medical instruments supplier’s stock valued at $150,000 after purchasing an additional 2,018 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Trading Up 0.2 %

NASDAQ XRAY opened at $30.92 on Thursday. The firm has a 50 day moving average of $32.70 and a two-hundred day moving average of $32.81. DENTSPLY SIRONA Inc. has a 52 week low of $26.27 and a 52 week high of $43.24. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $6.41 billion, a PE ratio of -49.87, a price-to-earnings-growth ratio of 1.23 and a beta of 0.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The business had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $972.61 million. During the same quarter in the prior year, the business posted $0.46 EPS. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a $0.16 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.07%. DENTSPLY SIRONA’s dividend payout ratio is presently -103.22%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on XRAY shares. Piper Sandler lifted their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Friday, January 12th. SVB Leerink started coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They issued an “outperform” rating and a $42.00 price objective for the company. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Finally, Barrington Research reiterated an “outperform” rating and set a $41.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Moderate Buy” and an average price target of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.